期刊文献+

艾康片制备工艺药效学筛选研究 被引量:1

Pharmacodynamics Research on the Extraction Technology of Aikang Tablets
下载PDF
导出
摘要 目的:从药效学角度筛选艾康片3种提取工艺在抑制肿瘤生长方面效果最佳者,为艾康片进一步工艺提取提供参考。方法:选取BALB/CA-nu裸小鼠,于右前肢腋皮下接种肿瘤细胞悬液建立移植性肺癌模型,建模后将鼠随机分为11组,分别为模型对照组,阳性药物对照组,艾康1号高、中、低,艾康2号高、中、低,艾康3号高、中、低剂量组。分组后当天开始灌胃给药,每日1次,连续21 d,每隔3日测定裸鼠的体质量及肿瘤体积,3周后取肿瘤组织,计算每组平均瘤重、肿瘤生长抑制率、肿瘤体积、相对肿瘤体积、相对肿瘤增殖率。结果:与模型对照组比较,艾康片3个样品各剂量组肿瘤体积及瘤块均明显下降(P<0.01)。艾康3号中剂量组的相对肿瘤增殖体积在给药期间与模型对照组比较有差异(P<0.05)。艾康3号中剂量组的相对肿瘤增殖率为28.72%,低于其它给药组。结论:艾康片对人肺腺癌细胞株(A549)裸鼠的肿瘤增长有一定的抑制作用,艾康片3号中剂量组对肿瘤的抑制作用最佳。 Objective: To investigate the optimal extraction technology of Aikang Tablets in terms of inhibiting tumor growth from the perspective of pharmacodynamics, thus to provide references for further extraction of Aikang Tablets. Methods: design three different doses groups (which is equivalent to 2 times, equimultiple, 1/2 times of clinical dosage ). Lung carcinoma xenografts were set up by inoculating A549 cells suspensionin to the right forlimb subcutaneously in the BALB/CA-nu nude mice. When tumor grew to about 100 mm 3, nude mice were randomly divided into the 11 groups: the model group, the positive control group(Compound Cyclophosphamide Tablets), the group of Aikang Tablet 1(high-dose, medium-dose and low-dose), the group of Aikang Tablet 2(high-dose, medium-dose and low-dose), and the group of Aikang Tablet 3(high-dose, medium-dose and low-dose). The medication was once per day for 21 days. The tumor volume and the mice weight were measured every four days. After three weeks, the tumor tissue were collected and weighted, tumor growth inhibition rate, tumor volume, relative tumor growth volume, and relative tumor proliferation rate were calculated at the same time. Results: The gross tumor volume and tumor mass were significantly reduced in the three groups of Aikang Tablets when compared to those in the control group( P <0.01). The relative tumor growth volume in the group of Aikang Tablets 3 of medium-dose was significantly lower than that of the control group( P <0.05). The relative tumor proliferation rate was 28.72% in the group of Aikang Tablets 3 of medium-dose, compared to that in the other medication groups. Conclusion: Aikang Tablets can inhibit tumor growth, medium dose of Aikang Tablets 3 has the best effect.
作者 姚荣妹 毛鑫 包蕾 高英杰 王彦礼 崔晓兰 YAO Rongmei;MAO Xin;BAO Lei;GAO Yingjie;WANG Yanli;CUI Xiaolan(Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China)
出处 《中医药学报》 CAS 2019年第2期68-71,共4页 Acta Chinese Medicine and Pharmacology
基金 国家"重大新药创制"科技重大专项(2014ZX09304306-006)
关键词 艾康片 药效学 工艺筛选 抑制肿瘤 Aikang Tablets Pharmacodynamics Optimization of extraction technology Tumor inhibition
  • 相关文献

参考文献3

二级参考文献52

  • 1许建平,谢青,张哉根,叶明福,陈意生,高广正,罗刚.人巨细胞肺癌裸鼠移植瘤中mts1和nm23-H1表达及其与肺癌淋巴结转移关系[J].临床与实验病理学杂志,2005,21(1):99-102. 被引量:1
  • 2王金万,孙燕,刘永煜,于起涛,张沂平,李凯,朱允中,周清华,侯梅,管忠震,李维廉,庄武,王东林,梁后杰,秦凤展,卢辉山,刘晓晴,孙红,张燕军,王杰军,罗素霞,杨瑞合,涂远荣,王秀问,宋恕平,周静敏,游丽芬,王竞,姚晨.重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J].中国肺癌杂志,2005,8(4):283-290. 被引量:626
  • 3邹小农.中国肺癌流行病学[J].中华肿瘤防治杂志,2007,14(12):881-883. 被引量:152
  • 4Sieqel R, Naishadham D, Jemal A. Cancer statistics, 2012 [ J]. CA Cancer J Clin, 2012,62( 1 ) : 10 - 29. 被引量:1
  • 5Mueller B M, Reisfeld R A. Potential of the scid mouse as a host for human tumors[ J]. Cancer Metastasis Rev, 1991,10 (3) : 193 - 200. 被引量:1
  • 6Bosma G C, Fried M, Custer R P, et al. Evidence of functional lymphocytes in some (leaky) scid mice[ J]. J Exp Med, 1988, 167(3) :1016 -33. 被引量:1
  • 7Dolgin E. Animal testing alternatives come alive in US [ J ]. Nat Med, 2010,16(12) :1348. 被引量:1
  • 8Fiehtner I, Rolff J, Soong R, et aL Animal testing alternatives come alive in US cell lung cancer xenografts as models for the i- dentification of predictive biomarkers [ J ]. Clin Cancer Res, 2008,14(20) :6456 -68. 被引量:1
  • 9Starkey J R, Rebane A K, Drobizhev M A, et al. New two-photon activated photodynamic therapy sensitizers induce xenograft tumor regressions after near-IR laser treatment through the body of the host mouse [ J]. Clin Cancer Res, 2008,14 (20) :6564 - 73. 被引量:1
  • 10Teicher B A. Tumor models for efficacy determination [ J ]. Mol Cancer Ther, 2006,5(10) :2435 -43. 被引量:1

共引文献46

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部